Strengthening Research and Partnerships at THSNA 2026 – NBDF
National Bleeding Disorders Foundation shared a post on LinkedIn:
“That’s a wrap on THSNA 2026!
We’re incredibly grateful to the NBDF staff who represented us at THSNA this past week.
From engaging in thoughtful panel discussions to being surrounded by leading voices in the field, this experience was a powerful reminder of the importance of collaboration and continued learning.
We were proud to share new findings from Community Voices in Research and see firsthand the impact of our research grant programs and educational resources.
We’re coming back to work filled with new ideas and ways for us to partner with health care providers and other bleeding disorders organizations.
We’re proud of the knowledge gained and relationships strengthened, and look forward to bringing these insights back to inform and elevate our work at NBDF.”
Dawn Rotellini, Chief Operating Officer at National Bleeding Disorders Foundation, shared this post on LinkedIn, adding:
“It was an excellent conference!
So proud of our team and proud of NBDFs resources being highlighted throughout.”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke